Spectrum of malignant and premalignant skin lesions in 505 adult subjects at risk of skin cancers
Patients at risk of skin cancers can develop varying types of cutaneous malignancies. However, some subjects may develop only one type of lesion. In this cross-sectional study, the spectrum of premalignant (PM... (Source: BMC Cancer)
Source: BMC Cancer - March 14, 2024 Category: Cancer & Oncology Authors: Reetta Nevakivi, Hanna Siiskonen, Salla Haimakainen and Ilkka T. Harvima Tags: Research Source Type: research

Role of beta-(1 →3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures
Beta-(1,3)(1,6)-D-glucan is a complex polysaccharide, which is found in the cell wall of various fungi, yeasts, bacteria, algae, barley, and oats and has immunomodulatory, anticancer and antiviral effects. In the... (Source: BMC Cancer)
Source: BMC Cancer - March 14, 2024 Category: Cancer & Oncology Authors: Abdelhadi Boulifa, Martin J. Raftery, Alexander Sebastian Franz én, Clarissa Radecke, Sebastian Stintzing, Jens-Uwe Blohmer and Gabriele Pecher Tags: Research Source Type: research

Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival
Adult head and neck rhabdomyosarcoma (HNRMS) is an exceptionally rare malignancy, and there is a paucity of data and research dedicated to understanding its characteristics and management in adult populations.... (Source: BMC Cancer)
Source: BMC Cancer - March 14, 2024 Category: Cancer & Oncology Authors: Dan Zhao, Fang Zhou, Weixin Liu, Zhou Huang, Xiaolong Xu, Baomin Zheng, Changqing Liu, Chujie Bai, Jiayong Liu, Yan Sun, Weihu Wang and Shaowen Xiao Tags: Research Source Type: research

Establishment of a risk prediction model for bowel preparation failure prior to colonoscopy
This study aimed to determine the factors that contribute to the failure of bowel preparation in patients undergoing colonoscopy and to develop a risk prediction model. (Source: BMC Cancer)
Source: BMC Cancer - March 14, 2024 Category: Cancer & Oncology Authors: Na Zhang, Miaomiao Xu and Xing Chen Tags: Research Source Type: research

A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry
Paucity and low evidence-level data on proton therapy (PT) represent one of the main issues for the establishment of solid indications in the PT setting. Aim of the present registry, the POWER registry, is to pro... (Source: BMC Cancer)
Source: BMC Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Daniela Alterio, Maria Giulia Vincini, Stefania Volpe, Luca Bergamaschi, Mattia Zaffaroni, Sara Gandini, Giulia Peruzzotti, Federica Cattani, Cristina Garibaldi, Barbara Alicja Jereczek-Fossa and Roberto Orecchia Tags: Study Protocol Source Type: research

Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway
Ribosomal RNA processing protein 15 (RRP15) has been found to regulate the progression of hepatocellular carcinoma (HCC). Nevertheless, the extent to which it contributes to the spread of HCC cells remains unc... (Source: BMC Cancer)
Source: BMC Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Tongtong Pan, Jinhai Li, Ouyang Zhang, Yuqin Zhu, Hongfei Zhou, Mengchen Ma, Yanwen Yu, Jiaojian Lyu, Yongping Chen and Liang Xu Tags: Research Source Type: research

Impact of timing and format of patient decision aids for breast cancer patients on their involvement in and preparedness for decision making - the IMPACTT randomised controlled trial protocol
After curative surgery for early-stage breast cancer, patients face a decision on whether to undergo surgery alone or to receive one or more adjuvant treatments, which may lower the risk of recurrence. Variati... (Source: BMC Cancer)
Source: BMC Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Bettina M ølri Knudsen, Stine Rauff Søndergaard, Dawn Stacey and Karina Dahl Steffensen Tags: Study Protocol Source Type: research

Survival time prediction in patients with high-grade serous ovarian cancer based on 18F-FDG PET/CT- derived inter-tumor heterogeneity metrics
This study aimed to assess the predictive accuracy of models utilizing quantitative 18F-FDG PET/CT derived inter-tumo... (Source: BMC Cancer)
Source: BMC Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Dianning He, Xin Zhang, Zhihui Chang, Zhaoyu Liu and Beibei Li Tags: Research Source Type: research

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial
Almost one third of cancer patients in the United States will develop brain metastases on an annual basis. Surgical resection is indicated in the setting of brain metastases for reasons, such as maximizing loc... (Source: BMC Cancer)
Source: BMC Cancer - March 12, 2024 Category: Cancer & Oncology Authors: David M. Routman, Ignacio Jusue-Torres, Paul D. Brown, Daniel M. Trifiletti, Sujay A. Vora, Desmond A. Brown, Ian F. Parney, Terry C. Burns and Elizabeth Yan Tags: Study Protocol Source Type: research

ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
TMEFF1 is a new protein involved in the physiological functions of the central nervous system, and we previously reported TMEFF1 can promote ovarian cancer. ST14 was determined to be involved in the processes ... (Source: BMC Cancer)
Source: BMC Cancer - March 11, 2024 Category: Cancer & Oncology Authors: Xin Nie, Lingling Gao, Mingjun Zheng, Shuang Wang, Caixia Wang, Xiao Li, Ouxuan Liu, Rui Gou, Juanjuan Liu and Bei Lin Tags: Research Source Type: research

Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer
Angiogenesis is crucial for tumor development, progression, and metastasizing. The most important regulator of angiogenesis is the vascular endothelial growth factor (VEGF) family, which is involved in multipl... (Source: BMC Cancer)
Source: BMC Cancer - March 11, 2024 Category: Cancer & Oncology Authors: Niina M äenpää, Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala, Minna Tanner, Outi Lahdenperä, Pia Vihinen, Peeter Karihtala, Pirkko-Liisa Kellokumpu-Lehtinen, Eeva Moilanen and Arja Jukkola Tags: Research Source Type: research

The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma
The impact of tumor-infiltrating neutrophils (TINs) on clinical outcomes has been reported in various cancer types, but their role in hepatocellular carcinoma (HCC) has not been fully evaluated. The aim of thi... (Source: BMC Cancer)
Source: BMC Cancer - March 11, 2024 Category: Cancer & Oncology Authors: Jung Hee Lee and Young Mi Hong Tags: Research Source Type: research

Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer
The sialic acid binding Ig like lectin 15 (Siglec-15) was previously identified as tumor immune suppressor gene in some human cancers with elusive molecular mechanism to be elucidated. The continuous focus on ... (Source: BMC Cancer)
Source: BMC Cancer - March 11, 2024 Category: Cancer & Oncology Authors: Xingzhi Li, Ziji Liang, Jiexin Pan, Meng Zhang, Jinli Liu, Rong Hu and Caiyan Liao Tags: Research Source Type: research

Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry
Population-based cancer quality registries are of great importance for the improvement of cancer care. However, little is known about the quality of recurrence data in cancer quality registries. The aim of thi... (Source: BMC Cancer)
Source: BMC Cancer - March 11, 2024 Category: Cancer & Oncology Authors: Sofia Palm ér, Carl Blomqvist, Marit Holmqvist, Henrik Lindman, Mats Lambe and Johan Ahlgren Tags: Research Source Type: research

FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression
FLI1 is an oncogenic transcription factor that promotes diverse malignancies through mechanisms that are not fully understood. Herein, FLI1 is shown to regulate the expression of Ubiquitin Associated and SH3 D... (Source: BMC Cancer)
Source: BMC Cancer - March 9, 2024 Category: Cancer & Oncology Authors: Jie Wang, Chunlin Wang, Anling Hu, Kunlin Yu, Yi Kuang, Babu Gajendran, Eldad Zacksenhaus, Klarke Michael Sample, Xiao Xiao, Wuling Liu and Yaacov Ben-David Tags: Research Source Type: research